Rejuvant’s CaAKG Supplement Becomes Core Requirement in Lionheart’s KLOTHO-UP™ Study and Klotho Wellness Program The post Lionheart Health and Rejuvant Rejuvant’s CaAKG Supplement Becomes Core Requirement in Lionheart’s KLOTHO-UP™ Study and Klotho Wellness Program The post Lionheart Health and Rejuvant

Lionheart Health and Rejuvant Partner to Compete in XPRIZE Healthspan Semi-Finals

2026/02/06 23:00
4 min read

Huntington Beach, California (Newsworthy.ai) Friday Feb 6, 2026 @ 7:00 AM Pacific —

Lionheart Health, a regenerative health and longevity technology company, today announced a strategic partnership with Rejuvant, the developer of the patented, sustained-release Calcium alpha-ketoglutarate (CaAKG) supplementation, as part of Lionheart Health’s participation in the XPRIZE Healthspan Semi-Finals. Lionheart Health was selected as a top 40 semi-finalists out of more than 600 entries in spring 2025.

Under the collaboration, Rejuvant’s CaAKG supplement—associated with peer-reviewed research demonstrating improvements in biological age markers—has been designated a mandatory core component of the Lionheart KLOTHO-UP™ Study and the broader Lionheart Klotho Wellness Program, both of which are central to Lionheart’s XPRIZE Healthspan initiative.

A Comprehensive, Technology-Driven Healthspan Platform

The Lionheart KLOTHO-UP™ Study integrates Rejuvant’s CaAKG supplementation within a multi-modal healthspan optimization framework designed to evaluate coordinated improvements across muscle, metabolic, immune, cardiovascular, and brain health domains.

In addition to Rejuvant CaAKG, all study participants receive:

  • SNiP Nutrition™ personalized supplements, customized based on genetic and biomarker profiles
  • Targeted Klotho-focused supplementation
  • Lionheart Health’s BodStim™ bioelectric exercise platform, delivering Klotho- and follistatin-elevating electrical muscle stimulation–enhanced exercise sessions (1 hour, 2–3 times per week)

This integrated approach reflects Lionheart’s belief that meaningful healthspan extension requires both lifestyle optimization and advanced biological technologies working in concert.

Deep, Longitudinal Measurement of Healthspan Outcomes

All enrollees in the KLOTHO-UP™ Study and Klotho Wellness Program undergo an extensive testing and evaluation protocol at baseline, 3 months, 6 months, and 12 months, including:

  • 461-biomarker comprehensive blood panel including klotho levels
  • AI-enhanced full-body MRI, with targeted organ and tissue analysis OPTIONAL
  • Muscle health – grip strength, 6 minute walk, muscle mass index, gait speed
  • Gut health, immunity strength and microbiome assessment
  • Breathing and sleep analysis OPTIONAL
  • Stress and inflammation profiling, including cortisol measurement OPTIONAL
  • Blood sugar and metabolic regulation analysis
  • Vascular and calcification assessment OPTIONAL
  • Joint health and mobility evaluation OPTIONAL
  • Sexual health assessment OPTIONAL
  • Vision and hearing evaluation OPTIONAL
  • Brain health testing, including cognition, memory, and mood metrics

This longitudinal design enables objective tracking of functional healthspan changes over time rather than reliance on single-endpoint or short-duration outcomes.

Visit > https://lionheartlongevity.com/treatment/klotho-wellness-program/ to book a consultation to learn more.

Leadership Perspectives

“Rejuvant’s CaAKG platform represents one of the most rigorously studied nutritional interventions in the biological aging space,” said a spokesperson for Lionheart Health. “By making CaAKG a mandatory core component of our XPRIZE Healthspan protocol, we are anchoring our program in validated metabolic biology while layering in advanced bioelectric, Klotho-focused, and personalized technologies.”

A representative from Rejuvant added, “We are excited to partner with Lionheart Health in the XPRIZE Healthspan Semi-Finals. This collaboration allows CaAKG supplementation to be evaluated within one of the most comprehensive, biomarker-driven healthspan programs ever assembled.”

About Lionheart Health

Lionheart Health is a regenerative health and longevity technology company developing integrated platforms focused on bioelectric control of regenerative protein expressions, Klotho-centric biology, personalized nutrition, and advanced diagnostics. Lionheart Health is an XPRIZE Healthspan Semi-Finalist, advancing multi-modal approaches designed to extend functional healthspan across muscle, immune, metabolic, cardiovascular, and brain systems. They are an Abbvie Allergan Innovation Award Winner. Finalist in 2025 Octane Life Sciences Technology Co of Year Award and Orange County Business Journal’s 2025 Innovator of Year competition. Recognized by Medtech Outlook Magazine as Stimulator Developer of Year 2025. 700+ patent claims issued, pending, in process, licensed or optioned covering healthspan longevity. Clinic data on hundreds of patients. Working with OEM manufacturer suppliers multiple FDA 510K market clearances.

About Rejuvant

Rejuvant is a longevity biotechnology company developing clinically researched and patented Calcium alpha-ketoglutarate (CaAKG) supplements aimed at supporting healthy aging. Rejuvant’s formulations are informed by peer-reviewed research and are designed for integration into advanced health optimization and longevity programs.

Media Contact:
Brian Hardy
Director of Marketing
Lionheart Health
[email protected]

Phone: (424) 291-2133. Clinics AI Receptionist Number 949-710-3100


This press release is distributed by the Newsworthy.ai™ Press Release Newswire – News Marketing Platform™. The reference URL for this press release is located here Lionheart Health and Rejuvant Partner to Compete in XPRIZE Healthspan Semi-Finals.

The post Lionheart Health and Rejuvant Partner to Compete in XPRIZE Healthspan Semi-Finals appeared first on citybuzz.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment?

Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment?

The post Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment? appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 17:39 Is dogecoin really fading? As traders hunt the best crypto to buy now and weigh 2025 picks, Dogecoin (DOGE) still owns the meme coin spotlight, yet upside looks capped, today’s Dogecoin price prediction says as much. Attention is shifting to projects that blend culture with real on-chain tools. Buyers searching “best crypto to buy now” want shipped products, audits, and transparent tokenomics. That frames the true matchup: dogecoin vs. Pepeto. Enter Pepeto (PEPETO), an Ethereum-based memecoin with working rails: PepetoSwap, a zero-fee DEX, plus Pepeto Bridge for smooth cross-chain moves. By fusing story with tools people can use now, and speaking directly to crypto presale 2025 demand, Pepeto puts utility, clarity, and distribution in front. In a market where legacy meme coin leaders risk drifting on sentiment, Pepeto’s execution gives it a real seat in the “best crypto to buy now” debate. First, a quick look at why dogecoin may be losing altitude. Dogecoin Price Prediction: Is Doge Really Fading? Remember when dogecoin made crypto feel simple? In 2013, DOGE turned a meme into money and a loose forum into a movement. A decade on, the nonstop momentum has cooled; the backdrop is different, and the market is far more selective. With DOGE circling ~$0.268, the tape reads bearish-to-neutral for the next few weeks: hold the $0.26 shelf on daily closes and expect choppy range-trading toward $0.29–$0.30 where rallies keep stalling; lose $0.26 decisively and momentum often bleeds into $0.245 with risk of a deeper probe toward $0.22–$0.21; reclaim $0.30 on a clean daily close and the downside bias is likely neutralized, opening room for a squeeze into the low-$0.30s. Source: CoinMarketcap / TradingView Beyond the dogecoin price prediction, DOGE still centers on payments and lacks native smart contracts; ZK-proof verification is proposed,…
Share
BitcoinEthereumNews2025/09/18 00:14
SEI Technical Analysis Feb 6

SEI Technical Analysis Feb 6

The post SEI Technical Analysis Feb 6 appeared on BitcoinEthereumNews.com. SEI is consolidating at the $0.08 level under general downtrend pressure; although RSI
Share
BitcoinEthereumNews2026/02/07 02:43
South Korean Crypto Exchange Accidentally Gave Away $95 Billion in Bitcoin

South Korean Crypto Exchange Accidentally Gave Away $95 Billion in Bitcoin

The post South Korean Crypto Exchange Accidentally Gave Away $95 Billion in Bitcoin appeared on BitcoinEthereumNews.com. In brief South Korean exchange Bithumb
Share
BitcoinEthereumNews2026/02/07 02:16